Bumper Offer - Urjas oil Just @ Rs. 1
Maxgalin ER 150 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Neuropathic Pain, Epilepsy, Anxiety are some of its major therapeutic uses. Secondary and off-label uses of Maxgalin ER 150 Mg Tablet have also been mentioned below.
The right dosage of Maxgalin ER 150 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Maxgalin ER 150 Mg Tablet side effects, there are can be others also. These have been listed below. These side effects of Maxgalin ER 150 Mg Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Maxgalin ER 150 Mg Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Maxgalin ER 150 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Maxgalin ER 150 Mg Tablet related warnings section.
The section on Maxgalin ER 150 Mg Tablet contraindications lists all such conditions.
Additionally, Maxgalin ER 150 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Maxgalin ER 150 Mg Tablet is not safe while driving, and is is not addictive in nature.
Maxgalin ER 150 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Maxgalin ER 150 Mg Tablet safe for pregnant women?
Maxgalin can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Maxgalin right away. Take your doctor's advice before taking it again.
Is the use of Maxgalin ER 150 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Maxgalin. It should only be taken after medical advice.
What is the effect of Maxgalin ER 150 Mg Tablet on the Kidneys?
Maxgalin rarely affects the kidneys.
What is the effect of Maxgalin ER 150 Mg Tablet on the Liver?
Maxgalin is completely safe for the liver.
What is the effect of Maxgalin ER 150 Mg Tablet on the Heart?
Maxgalin is completely safe for the heart.
Maxgalin ER 150 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Maxgalin ER 150 Mg Tablet unless your doctor advises you to do so -
Is this Maxgalin ER 150 Mg Tablet habit forming or addictive?
No, you will not get addicted to Maxgalin ER 150 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Maxgalin ER 150 Mg Tablet. So it is best to avoid driving.
Is it safe?
Maxgalin ER 150 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Maxgalin ER 150 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Maxgalin ER 150 Mg Tablet
Taking Maxgalin ER 150 Mg Tablet with food is safe.
Interaction between Alcohol and Maxgalin ER 150 Mg Tablet
Consumption of alcohol and Maxgalin ER 150 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
